Study finds GLP-1 receptor agonist use increases likelihood of antidepressant prescription
Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in Diabetes, Obesity, and Metabolism.
May 16, 2024
0
28